Lygos and ginkgo bioworks announce partnership to optimize production of biobased specialty chemicals

Strain development program aims to accelerate efforts to create sustainable chemicals berkeley, calif. and boston , nov. 11, 2022 /prnewswire/ -- lygos, inc., a vertically integrated provider of sustainable specialty ingredients, and ginkgo bioworks (nyse: dna), the leading horizontal platform for cell programming, today announced a multi-product research and development collaboration designed to optimize and scale production of sustainable specialty ingredients that can replace toxic petrochemistry, reclaim local manufacturing, and advance industrial bio-innovation.
DNA Ratings Summary
DNA Quant Ranking